Producing muscular relaxation during anaesthesia

Active Ingredient: Suxamethonium

Indication for Suxamethonium

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Suxamethonium is a short acting depolarising neuromuscular blocking agent for producing muscular relaxation during anaesthesia. It is used in anaesthesia as a muscle relaxant to facilitate endotracheal intubation, mechanical ventilation and a wide range of surgical and obstetric procedures.

It is also used to reduce the intensity of muscle contractions associated with Pharmacologically or electrically-induced convulsions.

For this indication, competent medicine agencies globally authorize below treatments:

20-150 mg

Route of admnistration

Intravenous

Defined daily dose

20 - 150 mg

Dosage regimen

From 20 To 150 mg once every day

Detailed description

The dosage for adults and children is dependent on body weight and the degree of muscular relaxation required. The usual single dose for an adult is in the range of 20 to 100mg intravenously, depending on the patient’s body weight and the degree of muscular relaxation required. Infants and young children are relatively resistant to suxamethonium.

Paediatric population

A suggested dose for children is in the range of 1 to 2mg/kg body weight, intravenously.

If necessary, the intramuscular route may be used and a dose up to 2.5mg/kg body weight may be given intramuscularly to adults or children to a maximum total of 150mg. For administration by continuous intravenous infusion, a 0.1 to 0.2% Solution may be used and the adult dose ranges from 2 to 5mg per minute.

Older people

Dosage requirements of suxamethonium in older patients are comparable to those for younger adults.

The elderly may be more susceptible to cardiac arrhythmias, especially if digitalis-like drugs are also being taken.

Dosage considerations

Suxamethonium is usually administered by the intravenous route. It is given intravenously after anaesthesia has been induced and should not be administered to the conscious patient. Assisted respiration is necessary.

Active ingredient

Suxamethonium

Suxamethonium is a short-acting depolarising neuromuscular blocking agent. Suxamethonium inhibits neuromuscular transmission by depolarising the motor end plates in skeletal muscle.

Read more about Suxamethonium

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.